Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Colman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Experimental Cell Research|December 8, 2007
The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinasesYuchuan Liu, Irma M Sainz, Yi Wu, et al.
The Journal of Biological Chemistry|July 29, 2006
New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A: a role for the unique 44-amino acid insertSu-Hwi Hung, Wei Zhang, Robin A Pixley, et al.
Thrombosis and Haemostasis|November 5, 2005
Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through AktVaibhav Katkade, Abigail A Soyombo, Irma Isordia-Salas, et al.
The American Journal of Gastroenterology|August 23, 2002
Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markersMassimo Devani, Massimo Cugno, Maurizio Vecchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2006
High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytesMohammad M Khan, Harlan N Bradford, Irma Isordia-Salas, et al.
Digestive Diseases and Sciences|May 22, 2003
Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel diseaseAntoni Stadnicki, Urszula Mazurek, Maciej Gonciarz, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2010
Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogenSabina T Khan, Robin A Pixley, Yuchuan Liu, et al.
The Journal of Biological Chemistry|April 24, 2002
Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogenTriantafyllos Chavakis, Nicole Boeckel, Sentot Santoso, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 13, 2007
Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivoSarmina Hassan, Irma M Sainz, Mohammad M Khan, et al.
Blood|July 5, 2003
The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammationIrma Isordia-Salas, Robin A Pixley, Hemant Parekh, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Experimental Cell Research|December 8, 2007
The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinasesYuchuan Liu, Irma M Sainz, Yi Wu, et al.
The Journal of Biological Chemistry|July 29, 2006
New insights from the structure-function analysis of the catalytic region of human platelet phosphodiesterase 3A: a role for the unique 44-amino acid insertSu-Hwi Hung, Wei Zhang, Robin A Pixley, et al.
Thrombosis and Haemostasis|November 5, 2005
Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through AktVaibhav Katkade, Abigail A Soyombo, Irma Isordia-Salas, et al.
The American Journal of Gastroenterology|August 23, 2002
Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markersMassimo Devani, Massimo Cugno, Maurizio Vecchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2006
High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytesMohammad M Khan, Harlan N Bradford, Irma Isordia-Salas, et al.
Digestive Diseases and Sciences|May 22, 2003
Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel diseaseAntoni Stadnicki, Urszula Mazurek, Maciej Gonciarz, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2010
Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogenSabina T Khan, Robin A Pixley, Yuchuan Liu, et al.
The Journal of Biological Chemistry|April 24, 2002
Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogenTriantafyllos Chavakis, Nicole Boeckel, Sentot Santoso, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 13, 2007
Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivoSarmina Hassan, Irma M Sainz, Mohammad M Khan, et al.
Blood|July 5, 2003
The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammationIrma Isordia-Salas, Robin A Pixley, Hemant Parekh, et al.
Pageof 6